Breakthrough T1D JDRF Grant Fuels 'SyneRegIm' Project to Revolutionize Type 1 Diabetes Treatment

April 6, 2022
Chantal Mathieu and Conny Gysemans, along with their research partners Nico De Leu and Willem Staels (Beta Cell Neogenesis Unit, VUB, Brussels, Belgium), have secured a prestigious JDRF research grant. JDRF (Juvenile Diabetes Research Foundation) is a leading non-profit organization with the mission to cure type 1 diabetes.
Share this post

In the project, the Leuven Diabetes Lab—BENE tandem will investigate innovative therapies that combine strategies to suppress the immune system—which, in type 1 diabetes, attacks the insulin-producing beta cells—with regenerative therapy aimed at helping repair the damaged beta cells. Their project is named "SyneRegIm": exploring the SYNErgistic effect of β-cell REGeneration and emerging IMmune intervention strategies to prevent and/or reverse type 1 diabetes.

‍

Support us

Choose to make a direct impact by contributing to a specific research project or by supporting the overarching goals of the Hippo & Friends Type 1 Diabetes Fund. 

By donating today, you enable early-career scientists to pursue groundbreaking research aimed at preventing and curing type 1 diabetes.
Every contribution moves us one step closer to breakthroughs that matter.

I want to make a direct donationI want to support Hippo & Friends